Company Ticker News July 19, 2021Biogen Is Still a Buy Despite Alzheimer's Drug Concerns, Analyst Says 0 0 Share
Company Ticker News July 16, 2021Here's why three hospitals are refusing to treat patients with Biogen's new Alzheimer's drug 0 0 Share
Video News July 15, 2021Biogen shares drop as big clinics say they won't administer controversial Alzheimer's drug 0 0 Share
Video News July 15, 2021FDA ‘abandoned its responsibility' in approving Biogen Alzheimer's drug: Doctor 0 0 Share
Company Ticker News July 15, 2021BIIB Stock: The Drug Ban News That Has Biogen Stumbling Today 0 0 Share
Company Ticker News July 15, 2021Biogen Shares Are Trading Lower As Cleveland Clinic, Mount Sinai Decline To Aduhelm Administration 0 0 Share
Company Ticker News July 15, 2021Biogen's Alzheimer's Drug Aduhelm Review Could Have Been Handled Differently, Says FDA Chief: STAT News 0 0 Share
Company Ticker News July 14, 2021FDA chief tells reporter 'move on' when pressed on Biogen Alzheimer's drug approval 0 0 Share
